Department of Medicine, Division of Cardiology, Tufts Medical Center, Boston, MA, USA.
Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Cancer Med. 2020 Sep;9(17):6122-6131. doi: 10.1002/cam4.3277. Epub 2020 Jul 9.
Observational studies suggest that regular physical activity may reduce cardiovascular morbidity and cancer recurrence in survivors of breast cancer. The association between physical activity and cardiac function with breast cancer therapy is unknown.
Self-reported physical activity was assessed using the Godin Leisure-Time Exercise Questionnaire at repeated intervals in a longitudinal cohort study of 603 breast cancer participants treated with doxorubicin and/or trastuzumab. Multivariable regression models estimated associations between clinical variables and physical activity. Generalized estimating equations adjusted for prespecified variables estimated associations between baseline physical activity and longitudinal echocardiographic measures of systolic and diastolic function.
Physical activity was low at baseline, prior to cancer therapy initiation. More than half of participants reported no moderate-strenuous physical activity, and only 12.1% met guideline recommended levels of physical activity. Physical activity increased after chemotherapy completion; however, only 26.0% of individuals were sufficiently active 3 years after cancer diagnosis. Body mass index, hyperlipidemia and higher cancer stage were significantly associated with lower total physical activity at baseline. Higher baseline physical activity was very modestly associated with an attenuation in the absolute decline in left ventricular ejection fraction over time (β 0.4%, 95% CI 0.1, 0.7, P = .02 for each 10-unit increase in total activity). There tended to be a cardioprotective association with cardiotoxicity risk, although this was not statistically significant (HR 0.83, 95% CI 0.66, 1.04, P = .097).
A small proportion of breast cancer patients and survivors are engaged in regular moderate-strenuous physical activity. While only modest associations between self-reported physical activity and left ventricular systolic function were observed, our findings do not exclude a cardioprotective benefit of exercise.
观察性研究表明,有规律的体育活动可能会降低乳腺癌患者的心血管发病率和癌症复发率。然而,体育活动与乳腺癌治疗后心脏功能的关系尚不清楚。
在一项对 603 名接受多柔比星和/或曲妥珠单抗治疗的乳腺癌患者进行的纵向队列研究中,多次间隔使用 Godin 休闲时间运动问卷评估自我报告的体育活动。多变量回归模型估计了临床变量与体育活动之间的关系。广义估计方程调整了预设变量,以估计基线体育活动与纵向超声心动图收缩和舒张功能测量值之间的关系。
在开始癌症治疗之前,基线时的体育活动水平较低。超过一半的参与者报告没有中等强度-剧烈的体育活动,只有 12.1%的人达到了推荐的体育活动水平。化疗完成后,体育活动增加;然而,只有 26.0%的人在癌症诊断后 3 年内足够活跃。体重指数、血脂异常和更高的癌症分期与基线时总体育活动量较低显著相关。基线时较高的体育活动量与左心室射血分数随时间绝对下降幅度的适度降低相关(β 0.4%,95%CI 0.1,0.7,P 分别为每增加 10 个单位总活动量的 0.02)。虽然与心脏毒性风险存在保护心脏的关联,但这并不具有统计学意义(HR 0.83,95%CI 0.66,1.04,P 分别为 0.097)。
很少有乳腺癌患者和幸存者经常进行中等强度-剧烈的体育活动。虽然自我报告的体育活动与左心室收缩功能之间仅观察到适度的关联,但我们的研究结果并不能排除运动的心脏保护作用。